REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro De Endocrinologia Pediatrica Y Diabetes En Ninos Yadolescentes S.A.S. Sigla Cenped N&A S.A.S. (Colombia)

Main Activities: Other Ambulatory Health Care Services
Full name: Centro De Endocrinologia Pediatrica Y Diabetes En Ninos Yadolescentes S.A.S. Sigla Cenped N&A S.A.S. Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Centro De Endocrinologia Pediatrica Y Diabetes En Ninos Yadolescentes S.A.S. Sigla Cenped N&A S.A.S. is an enterprise located in Colombia, with the main office in Barranquilla. It operates in the Other Ambulatory Health Care Services industry. The company was established on July 31, 2017. The latest financial highlights indicate a net sales revenue increase of 13.06% in 2022. Its total assets grew by 29.7% over the same period. The enterprise’s net profit margin decreased by 7.2% in 2022.

Headquarters
Cr 30 # 1 - 850 Cs 625 Clinica Porto Azul
Barranquilla; Atlantico;

Contact Details: Purchase the Centro De Endocrinologia Pediatrica Y Diabetes En Ninos Yadolescentes S.A.S. Sigla Cenped N&A S.A.S. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Centro De Endocrinologia Pediatrica Y Diabetes En Ninos Yadolescentes S.A.S. Sigla Cenped N&A S.A.S. report to view the information.
Incorporation Date:
July 31, 2017
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Centro De Endocrinologia Pediatrica Y Diabetes En Ninos Yadolescentes S.A.S. Sigla Cenped N&A S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
13.06%
Total operating revenue
13.06%
Operating profit (EBIT)
-12.74%
Net Profit (Loss) for the Period
-13.58%
Total assets
29.7%
Total equity
30.29%
Operating Profit Margin (ROS)
-7.11%
Net Profit Margin
-7.2%
Return on Equity (ROE)
-18.43%
Quick Ratio
0.79%
Cash Ratio
2.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?